Učitavanje...

Higher Doses of Subcutaneous IgG Reduce Resource Utilization in Patients with Primary Immunodeficiency

The recommended dose of IgG in primary immunodeficiency (PID) has been increasing since its first use. This study aimed to determine if higher subcutaneous IgG doses resulted in improved patient outcomes by comparing results from two parallel clinical studies with similar design. One patient cohort...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Haddad, Elie, Berger, Melvin, Wang, Edward C. Y., Jones, Christopher A., Bexon, Martin, Baggish, Jeffrey S.
Format: Artigo
Jezik:Inglês
Izdano: Springer US 2011
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3305876/
https://ncbi.nlm.nih.gov/pubmed/22193916
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10875-011-9631-6
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!